Elucidating the specific pharmacological system of action (MOA) of naturally happening compounds may be tough. Whilst Tarselli et al. (sixty) made the first de novo artificial pathway to conolidine and showcased that this naturally transpiring compound proficiently suppresses responses to both chemically induced and inflammation-derived pain, the p